Overview: AFB Culture Rapid TestIntroduction: The AFB Culture Rapid Test detects Mycobacterium tuberculosis, causing tuberculosis with symptoms like cough or weight loss. Following 2023 IDSA guidelines, it uses culture techniques for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in bacteriology for patients with suspected tuberculosis.
Other Names: AFB Culture Assay, Tuberculosis Test.
FDA Status: Laboratory-developed test (LDT), meeting bacteriology standards for diagnostic accuracy.
Historical Milestone: AFB culture testing began in the 1900s with tuberculosis research. Rapid culture methods emerged in the 1990s, and by the 2000s, automated systems improved accuracy.
Purpose: Diagnoses tuberculosis, guides antituberculous therapy, and monitors Mycobacterium presence in patients with cough or weight loss.
Test Parameters: 1. Mycobacterium Tuberculosis
Pretest Condition: No fasting required. Collect sputum, bronchoalveolar lavage, tissue, or body fluid at any time. Report symptoms like cough or weight loss, and list recent TB exposure.
Specimen: 5-10 mL sputum (sterile container), 5-10 mL bronchoalveolar lavage (sterile container), 0.5-2 cma³ tissue (sterile container), or 5-10 mL body fluid (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document cough, weight loss, or history of TB exposure. Include current medications, especially antituberculous drugs.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antituberculous therapy.
Procedural Considerations: Uses rapid culture techniques (e.g., MGIT) to detect Mycobacterium tuberculosis. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Recent antituberculous drugs or contamination can affect results. Poor sample quality reduces sensitivity.
Clinical Significance: Positive culture results confirm tuberculosis, prompting antituberculous therapy. Negative results may require PCR or smear testing.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation.
Additional Supporting Tests: TB PCR, AFB smear, or chest imaging to confirm tuberculosis or assess complications.
Test Limitations: False negatives may occur with low bacterial load. Results require clinical correlation.
References: IDSA Tuberculosis Guidelines, 2023; Clinical Infectious Diseases, Nahid P, 2022.
